Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit (original) (raw)

Nature Cell Biology volume 9, pages 225–232 (2007)Cite this article

A Corrigendum to this article was published on 01 March 2007

Abstract

The retinoblastoma protein (pRB) negatively regulates the progression from G1 to S phase of the cell cycle, in part, by repressing E2F-dependent transcription1. pRB also possesses E2F-independent functions that contribute to cell-cycle control — for example, during pRB-mediated cell-cycle arrest pRB associates with Skp2, the F-box protein of the Skp1–Cullin–F-box protein (SCF) E3 ubiquitin ligase complex, and promotes the stability of the cyclin-dependent kinase-inhibitor p27Kip1 through an unknown mechanism2,3. Degradation of p27Kip1 is mediated by ubiquitin-dependent targeting of p27Kip1 by SCF –Skp2 (ref. 4). Here, we report a novel interaction between pRB and the anaphase-promoting complex/cyclosome (APC/C) that controls p27Kip1 stability by targeting Skp2 for ubiquitin-mediated degradation. Cdh1, an activator of APC/C, not only interacts with pRB but is also required for a pRB-induced cell-cycle arrest. The results reveal an unexpected physical convergence between the pRB tumour-suppressor protein and E3 ligase complexes, and raise the possibility that pRB may direct APC/C to additional targets during pRB-mediated cell-cycle exit.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Classon, M. & Harlow E. The retinoblastoma tumour suppressor in development and cancer. Nature Rev. Cancer 2, 910–917 (2002).
    Article CAS Google Scholar
  2. Alexander, K. & Hinds P. W. Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence. Mol. Cell. Biol. 21, 3616–3631 (2001).
    Article CAS PubMed PubMed Central Google Scholar
  3. Ji, P. et al. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell. 16, 47–58 (2004).
    Article CAS PubMed Google Scholar
  4. Amati, B. & Vlach J. Kip1 meets SKP2: new links in cell-cycle control. Nature Cell Biol. 1, E91–E93 (1999).
    Article CAS PubMed Google Scholar
  5. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995).
    Article CAS PubMed Google Scholar
  6. Thomas, D. M. et al. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J. Cell. Biol. 167, 925–934 (2004).
    Article CAS PubMed PubMed Central Google Scholar
  7. Bloom, J. & Pagano M. Deregulated degradation of the cdk inhibitor p27 and malignant transformation. Semin. Cancer Biol. 13, 41–47 (2003).
    Article CAS PubMed Google Scholar
  8. Castro, A. et al. The anaphase-promoting complex: a key factor in the regulation of cell cycle. Oncogene 24, 314–325 (2005).
    Article CAS PubMed Google Scholar
  9. Fay, D. S., Keenan S. & Han M. fzr-1 and lin-35/Rb function redundantly to control cell proliferation in C. elegans as revealed by a nonbiased synthetic screen. Genes Dev. 16, 503–517 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  10. Dick, F. A., Sailhamer E. & Dyson N. J. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 20, 3715–3727 (2000).
    Article CAS PubMed PubMed Central Google Scholar
  11. Dick, F. A. & Dyson N. J. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins. J. Virol. 76, 6224–6234 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  12. Isaac, C. E. et al. The retinoblastoma protein regulates pericentric heterochromatin. Mol. Cell. Biol. 26, 3659–3671 (2006).
    Article CAS PubMed PubMed Central Google Scholar
  13. Kraft, C. et al. The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol. Cell. 18, 543–553 (2005).
    Article CAS PubMed Google Scholar
  14. Sorensen, C. S. et al. Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol. Cell. Biol. 20, 7613–7623 (2000).
    Article CAS PubMed PubMed Central Google Scholar
  15. Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194–198 (2004).
    Article CAS PubMed Google Scholar
  16. Bashir, T. et al. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. Nature. 428, 190–193 (2004).
    Article CAS PubMed Google Scholar
  17. Dickins, R. A. et al. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nature Genet. 37, 1289–1295 (2005).
    Article CAS PubMed Google Scholar
  18. Rape, M., Reddy S. K. & Kirschner M. W. The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 12, 89–103 (2006).
    Article Google Scholar
  19. Turnell, A. S. et al. The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression. Nature 438, 690–695 (2005).
    Article CAS PubMed Google Scholar
  20. Stroschein, S. L. et al. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev. 15, 2822–2836 (2001).
    CAS PubMed PubMed Central Google Scholar
  21. Wan, Y., Liu X. & Kirschner M. W. The anaphase-promoting complex mediates TGF-β signaling by targeting SnoN for destruction. Mol. Cell. 8, 1027–1039 (2001).
    Article CAS PubMed Google Scholar
  22. Benevolenskaya, E. V. et al. Binding of pRB to the PHD protein RBP2 promotes cellular differentiation. Mol. Cell. 18, 623–635 (2005).
    Article CAS PubMed Google Scholar
  23. Miyake, S. et al. Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle. Mol. Cell. Biol. 20, 8889–8902 (2000).
    Article CAS PubMed PubMed Central Google Scholar
  24. Lasorella, A. et al. Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature 442, 471–474 (2006).
    Article CAS PubMed Google Scholar
  25. Ang, X. L. & Harper J. W. Interwoven ubiquitination oscillators and control of cell cycle transitions. Sci STKE e31 (2004).
  26. van Roessel, P. et al. Independent regulation of synaptic size and activity by the anaphase-promoting complex. Cell 119, 707–718 (2004).
    Article CAS PubMed Google Scholar
  27. Dick, F. A. & Dyson N. J. pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol. Cell. 12, 639–649 (2003).
    Article CAS PubMed Google Scholar
  28. Dignam, J. D., Lebovitz R. M. & Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475–1489 (1983).
    Article CAS PubMed PubMed Central Google Scholar
  29. Imaki, H. et al. Cell cycle-dependent regulation of the Skp2 promoter by GA-binding protein. Cancer Res. 63, 4607–4613 (2003).
    CAS PubMed Google Scholar
  30. Wirbelauer, C. et al. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. EMBO J. 19, 5362–5375 (2000).
    Article CAS PubMed PubMed Central Google Scholar
  31. Zhang, H. et al. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell 82, 915–925 (1995).
    Article CAS PubMed Google Scholar
  32. Vernell, R., Helin K. & Muller H. Identification of target genes of the p16INK4A-pRB-E2F pathway. J. Biol. Chem. 278, 46124–46137 (2003).
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

We thank: C. Pfleger for numerous APC/C-related plasmids; R. Watson for Myc-tagged pRB, p107, p130 plasmids; S. Lowe for U2OS shRB cell line; J. Rocco for pcDNA6/TR and pcDNA4/TO plasmids; and B. Schulman for the CMV–Myc–Skp2 plasmid. We also like to thank P. Hinds and K. Münger for helpful comments on the manuscript. This study was supported by National Institutes of Health (NIH) grant CA64402 to N.J.D and by the Massachusetts General Hospital Fund for Medical Discovery to U.K.B.

Author information

Authors and Affiliations

  1. Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, MA 02129, Massachusetts, USA
    Ulrich K. Binné, Marie K. Classon, Anders M. Näär & Nicholas J. Dyson
  2. Department of Biochemistry, Schulich School of Medicine, London, N6A 4L6, Ontario, Canada
    Frederick A. Dick
  3. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, Massachusetts, USA
    Wenyi Wei & William G. Kaelin Jr.
  4. Department of Systems Biology, Harvard Medical School, Boston, MA 02115, Massachusetts, USA
    Michael Rape
  5. Howard Hughes Medical Institute and Brigham and Women's Hospital, Boston, MA 02115, Massachusetts, USA
    William G. Kaelin Jr.
  6. Department of Cell Biology, Harvard Medical School, Boston, MA 02115, Massachusetts, USA
    Anders M. Näär

Authors

  1. Ulrich K. Binné
    You can also search for this author inPubMed Google Scholar
  2. Marie K. Classon
    You can also search for this author inPubMed Google Scholar
  3. Frederick A. Dick
    You can also search for this author inPubMed Google Scholar
  4. Wenyi Wei
    You can also search for this author inPubMed Google Scholar
  5. Michael Rape
    You can also search for this author inPubMed Google Scholar
  6. William G. Kaelin Jr.
    You can also search for this author inPubMed Google Scholar
  7. Anders M. Näär
    You can also search for this author inPubMed Google Scholar
  8. Nicholas J. Dyson
    You can also search for this author inPubMed Google Scholar

Corresponding authors

Correspondence toAnders M. Näär or Nicholas J. Dyson.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Binné, U., Classon, M., Dick, F. et al. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.Nat Cell Biol 9, 225–232 (2007). https://doi.org/10.1038/ncb1532

Download citation

This article is cited by

Associated content